Pharmaceutical composition of curing endometriosis uterina

The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000mg of ferulic acid (or sodium ferulate) as well as 30 to 1200mg of tetrahydropalmatine (or tetrahydropalmatine sulfate). The pharmaceutical composition also comprises pharmaceutically acceptable adjuvant which is prepared into any medicament form suitable to be used in clinic. The invention aims at the pathology of the endometriosis uterine and adopts the active components of Chinese herbs such as ligustrazine, ferulic acid and tetrahydropalmatine with reliable pathology effects to provide a novel pharmaceutical composition which can resist the vein hyperplasia of ectopic endometrium, reduce the level of estrogen, raise the level of progestational hormone, resist inflammatory, kill pain and adjust immunity, thereby realizing the treatment to the endometriosis uterine.